Generic drug sponsors would know whether their inactive ingredient guesses are right sooner under a provision in the House FDA user fee reauthorization bill. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
